Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Project:Antibiotic Guidance

Categories:RCT

79 Publications found

A randomized trial to compare procalcitonin and C-reactive protein in assessing severity of sepsis and in guiding antibacterial therapy in Egyptian critically ill patients.

b

Irish journal of medical science

November 1, 2021

p Antibiotic Guidance

c Change patient management Highlighted RCT
Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study.

b

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

May 1, 2021

p Antibiotic Guidance

c Change patient management Clinical outcomes Operational efficiencies RCT
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.

b

American journal of respiratory and critical care medicine

January 15, 2021

p Antibiotic Guidance

c Change patient management Clinical outcomes Highlighted Operational efficiencies RCT
Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial.

b

Anaesthesiology intensive therapy

January 1, 2021

p Antibiotic Guidance

c Change patient management RCT
2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.

b

PloS one

January 1, 2021

p Antibiotic Guidance

c Change patient management Clinical outcomes RCT
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.

b

JAMA

June 2, 2020

p Antibiotic Guidance

c Change patient management Clinical outcomes RCT
Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers.

b

Critical care (London, England)

June 1, 2020

p Antibiotic Guidance

c Change patient management RCT
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.

b

Health technology assessment (Winchester, England)

March 1, 2020

p Antibiotic Guidance

c Change patient management Clinical outcomes Highlighted Operational efficiencies Patient-centeredness RCT
Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18.

b

European journal of heart failure

February 1, 2020

p Antibiotic Guidance

c Change patient management Clinical outcomes RCT
Clinical Utility of Procalcitonin in the Diagnosis of Pneumonia.

b

Clinical chemistry

December 1, 2019

p Antibiotic Guidance

c Change patient management Clinical outcomes RCT